Familial adenomatous polyposis

Discovery of a family and its management in a Cancer Genetics Clinic

Henry T. Lynch, Susan T. Tinley, Jane Lynch, Jon Vanderhoof, Stephen J. Lemon

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

BACKGROUND. Familial adenomatosis polyposis (FAP) is a prototype model for hereditary cancer. The adenomatous polyposis coli (APC) germline mutation, when identified within an FAP family, provides a powerful basis for early diagnosis. Indeed, the location of intragenic mutations in this large APC gene may distinguish the attenuated FAP variant (mutations proximal to 5') from classic FAP (mutations distal to 5'). METHODS. The authors describe a family with classic FAP that was evaluated at the authors' Hereditary Cancer Prevention Clinic (HCPC). RESULTS. The family history was extended from the original 10 to 32 family members. Medical records confirmed that six were affected with FAP and an additional 10 were reported by family members to be affected. CONCLUSIONS. HCPC clinics provide an invaluable support system for the physician and patient community in which genetic counseling, DNA testing when appropriate, and highly targeted surveillance and management options can be provided to all available members of the extended kindred. Because there are >200 differing hereditary cancer-prone syndromes, most of which will not involve such striking premonitory physical signs as in FAP, such clinics can provide an invaluable service to high risk patients.

Original languageEnglish
Pages (from-to)614-620
Number of pages7
JournalCancer
Volume80
Issue number3 SUPPL.
StatePublished - 1997

Fingerprint

Adenomatous Polyposis Coli
Neoplasms
Mutation
Hereditary Neoplastic Syndromes
APC Genes
Germ-Line Mutation
Genetic Counseling
Medical Records
Early Diagnosis
Physicians
DNA

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Lynch, H. T., Tinley, S. T., Lynch, J., Vanderhoof, J., & Lemon, S. J. (1997). Familial adenomatous polyposis: Discovery of a family and its management in a Cancer Genetics Clinic. Cancer, 80(3 SUPPL.), 614-620.

Familial adenomatous polyposis : Discovery of a family and its management in a Cancer Genetics Clinic. / Lynch, Henry T.; Tinley, Susan T.; Lynch, Jane; Vanderhoof, Jon; Lemon, Stephen J.

In: Cancer, Vol. 80, No. 3 SUPPL., 1997, p. 614-620.

Research output: Contribution to journalArticle

Lynch, HT, Tinley, ST, Lynch, J, Vanderhoof, J & Lemon, SJ 1997, 'Familial adenomatous polyposis: Discovery of a family and its management in a Cancer Genetics Clinic', Cancer, vol. 80, no. 3 SUPPL., pp. 614-620.
Lynch HT, Tinley ST, Lynch J, Vanderhoof J, Lemon SJ. Familial adenomatous polyposis: Discovery of a family and its management in a Cancer Genetics Clinic. Cancer. 1997;80(3 SUPPL.):614-620.
Lynch, Henry T. ; Tinley, Susan T. ; Lynch, Jane ; Vanderhoof, Jon ; Lemon, Stephen J. / Familial adenomatous polyposis : Discovery of a family and its management in a Cancer Genetics Clinic. In: Cancer. 1997 ; Vol. 80, No. 3 SUPPL. pp. 614-620.
@article{fc56f76d0c594b38a5629b22c64024b5,
title = "Familial adenomatous polyposis: Discovery of a family and its management in a Cancer Genetics Clinic",
abstract = "BACKGROUND. Familial adenomatosis polyposis (FAP) is a prototype model for hereditary cancer. The adenomatous polyposis coli (APC) germline mutation, when identified within an FAP family, provides a powerful basis for early diagnosis. Indeed, the location of intragenic mutations in this large APC gene may distinguish the attenuated FAP variant (mutations proximal to 5') from classic FAP (mutations distal to 5'). METHODS. The authors describe a family with classic FAP that was evaluated at the authors' Hereditary Cancer Prevention Clinic (HCPC). RESULTS. The family history was extended from the original 10 to 32 family members. Medical records confirmed that six were affected with FAP and an additional 10 were reported by family members to be affected. CONCLUSIONS. HCPC clinics provide an invaluable support system for the physician and patient community in which genetic counseling, DNA testing when appropriate, and highly targeted surveillance and management options can be provided to all available members of the extended kindred. Because there are >200 differing hereditary cancer-prone syndromes, most of which will not involve such striking premonitory physical signs as in FAP, such clinics can provide an invaluable service to high risk patients.",
author = "Lynch, {Henry T.} and Tinley, {Susan T.} and Jane Lynch and Jon Vanderhoof and Lemon, {Stephen J.}",
year = "1997",
language = "English",
volume = "80",
pages = "614--620",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Familial adenomatous polyposis

T2 - Discovery of a family and its management in a Cancer Genetics Clinic

AU - Lynch, Henry T.

AU - Tinley, Susan T.

AU - Lynch, Jane

AU - Vanderhoof, Jon

AU - Lemon, Stephen J.

PY - 1997

Y1 - 1997

N2 - BACKGROUND. Familial adenomatosis polyposis (FAP) is a prototype model for hereditary cancer. The adenomatous polyposis coli (APC) germline mutation, when identified within an FAP family, provides a powerful basis for early diagnosis. Indeed, the location of intragenic mutations in this large APC gene may distinguish the attenuated FAP variant (mutations proximal to 5') from classic FAP (mutations distal to 5'). METHODS. The authors describe a family with classic FAP that was evaluated at the authors' Hereditary Cancer Prevention Clinic (HCPC). RESULTS. The family history was extended from the original 10 to 32 family members. Medical records confirmed that six were affected with FAP and an additional 10 were reported by family members to be affected. CONCLUSIONS. HCPC clinics provide an invaluable support system for the physician and patient community in which genetic counseling, DNA testing when appropriate, and highly targeted surveillance and management options can be provided to all available members of the extended kindred. Because there are >200 differing hereditary cancer-prone syndromes, most of which will not involve such striking premonitory physical signs as in FAP, such clinics can provide an invaluable service to high risk patients.

AB - BACKGROUND. Familial adenomatosis polyposis (FAP) is a prototype model for hereditary cancer. The adenomatous polyposis coli (APC) germline mutation, when identified within an FAP family, provides a powerful basis for early diagnosis. Indeed, the location of intragenic mutations in this large APC gene may distinguish the attenuated FAP variant (mutations proximal to 5') from classic FAP (mutations distal to 5'). METHODS. The authors describe a family with classic FAP that was evaluated at the authors' Hereditary Cancer Prevention Clinic (HCPC). RESULTS. The family history was extended from the original 10 to 32 family members. Medical records confirmed that six were affected with FAP and an additional 10 were reported by family members to be affected. CONCLUSIONS. HCPC clinics provide an invaluable support system for the physician and patient community in which genetic counseling, DNA testing when appropriate, and highly targeted surveillance and management options can be provided to all available members of the extended kindred. Because there are >200 differing hereditary cancer-prone syndromes, most of which will not involve such striking premonitory physical signs as in FAP, such clinics can provide an invaluable service to high risk patients.

UR - http://www.scopus.com/inward/record.url?scp=0030762569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030762569&partnerID=8YFLogxK

M3 - Article

VL - 80

SP - 614

EP - 620

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3 SUPPL.

ER -